📰 Alpn News
Alpn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpn. Real-time updates on events, politics, business and more.
April 22, 2024
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and...
April 11, 2024
See the latest Alpine Immune Sciences Inc stock price (ALPN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
April 5, 2024
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) traded down 5.6% on Wednesday . The company traded as low as $36.80 and last traded at $37.02. 583,722 shares were traded during trading, a decline of 48% from the average session volume of 1,126,938 shares. The stock had previously closed at $39.21. Analyst […]
April 3, 2024
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have covered the stock in the […]
February 19, 2024
Wolfe Research started coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage issued an outperform rating and a $44.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Royal Bank of Canada lifted their target […]
February 15, 2024
Research analysts at Wolfe Research initiated coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) in a report released on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $44.00 price target on the biotechnology company’s stock. Wolfe Research’s price target points to a potential upside of 51.05% from the […]
February 6, 2024
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s share price traded down 4% during trading on Tuesday . The stock traded as low as $26.34 and last traded at $26.34. 347,216 shares changed hands during trading, a decline of 65% from the average session volume of 991,954 shares. The stock had previously closed at […]
January 16, 2024
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 3,980,000 shares, an increase of 32.7% from the December 15th total of 3,000,000 shares. Based on an average daily volume of 788,500 shares, the short-interest […]
January 10, 2024
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) were up 3.8% during trading on Wednesday . The stock traded as high as $20.31 and last traded at $20.25. Approximately 255,066 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 425,013 shares. The stock had previously […]
December 25, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) has earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued a report on the stock in […]